End-Stage Kidney Disease (ESKD) and Chronic Kidney Disease (CKD) Progression among a Hispanic/Latino Population with Primary Immunoglobulin A Nephropathy (IgAN)

https://storage.unitedwebnetwork.com/files/1099/d97ce6064ebaa8e24178f5d2f1b76a5c.pdf
End-Stage Kidney Disease (ESKD) and Chronic Kidney Disease (CKD) Progression among a Hispanic/Latino Population with Primary Immunoglobulin A Nephropathy (IgAN)
John
Sim
Nancy Cannizzaro nancy.takahashi@kp.org Kaiser Permanente Southern California Research and Evaluation Pasadena
Qiaoling Chen qiaoling.chen@kp.org Kaiser Permanente Southern California Research and Evaluation Pasadena
Sasikiran Nunna Sasikiran.Nunna@otsuka-us.com Otsuka America Pharmaceutical Inc Development and Commercialization Rockville, MD
Ancilla W Fernandes Ancilla.Fernandes@otsuka-us.com Otsuka America Pharmaceutical Inc Development and Commercialization Rockville, MD
Cibele Pinto Cibele.Pinto@otsuka-us.com Otsuka America Pharmaceutical Inc Development and Commercialization Rockville, MD
Mohit Mathur mmathur@visterrainc.com Visterra Inc Development and Commercialization Waltham, MA